Avion Wealth’s Moderna MRNA Stock Holding History

Avion Wealth’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9K	Buy	189 +53	+39%	+$2.47K	﹤0.01%	522
2025 Q4	$4K	Buy	136 +80	+143%	+$2.17K	﹤0.01%	713
2025 Q3	$1K	Sell	56 -75	-57%	-$2.09K	﹤0.01%	1058
2025 Q2	$3K	Buy	131 +119	+992%	+$3.13K	﹤0.01%	732
2025 Q1	$0	Buy	+12	New	+$426	﹤0.01%	1237
2024 Q4	–	Sell	-31	Closed	-$2K	–	1181
2024 Q3	$2K	Sell	31 -23	-43%	-$2.11K	﹤0.01%	701
2024 Q2	$6K	Sell	54 -20	-27%	-$2.53K	﹤0.01%	435
2024 Q1	$8K	Buy	74 +8	+12%	+$806	﹤0.01%	357
2023 Q4	$7K	Buy	66 +37	+128%	+$3.11K	﹤0.01%	333
2023 Q3	$2K	Buy	29 +25	+625%	+$2.79K	﹤0.01%	502
2023 Q2	$0	Buy	+4	New	+$534	﹤0.01%	930

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return